Logo-aim
Original Article

1. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population
Mojtaba Lotfaliany, Farzad Hadaegh, Samaneh Asgari, Mohammad Ali Mansournia, Fereidoun Azizi, Brian Oldenburg, Davood Khalili*
Arch Iran Med. 2019;22(3): 116-124.
PMID: 31029067     Scopus ID: 85065434167    
Article
PDF
XML
Cited By:
1
6
Original Article COVID-19

2. Impact of Mass Screening on the Number of Confirmed Cases, Recovered Cases, and Deaths Due to COVID-19 in Iran: An Interrupted Time Series Analysis
Moslem Taheri Soodejani ORCID, Seyyed Mohammad Tabatabaei, Ali Dehghani, Willi McFarland, Hamid Sharifi* ORCID
Arch Iran Med. 2020;23(11): 776-781. doi: 10.34172/aim.2020.103
Scopus ID: 85096631324    
Article
PDF
XML
Cited By:
4
5
Original Article

3. Audit of the Congenital Hypothyroidism Screening Program in 15 Provinces of Iran
Ladan Mehran, Shahin Yarahmadi, Davood Khalili, Mehdi Hedayati, Atieh Amouzegar, Pouria Mousapour, Nasrin Ajang, Fereydoun Azizi*
Arch Iran Med. 2019;22(6): 310-317.
PMID: 31356097     Scopus ID: 85070755660    
Article
PDF
XML
Cited By:
2
2
Original Article

4. Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study
Hamideh Salimzadeh* ORCID, Catherine Sauvaget, Alireza Delavari, Anahita Sadeghi, Mohammad Amani, Sepideh Salimzadeh, Azita Karimi, Ali Ghanbari Motlagh, Eric Lucas, Partha Basu, Reza Malekzadeh
Arch Iran Med. 2023;26(3): 138-146. doi: 10.34172/aim.2023.22
PMCID: PMC10685729     PMID: 37543936     Scopus ID: 85166777197    
Article
PDF
Suppl 1
XML
Cited By:
0
1
1
Original Article

5. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran
Hamideh Salimzadeh, Faraz Bishehsari, Catherine Sauvaget, Mohammad Amani, Gholamreza Hamzehloo, Ali Nikfarjam, Shahin Merat, Alireza Delavari*, Reza Malekzadeh
Arch Iran Med. 2017;20(12): 726-733.
PMID: 29664311     Scopus ID: 85044336283    
Article
PDF
XML
Cited By:
4
8
Original Article

6. Pattern of Participation in Colorectal Cancer Screening from a Population-Based Screening Program in Iran
Farimah Rahimi ORCID, Reza Rezayatmand* ORCID, Elaheh Najafi, Zahra Ravankhah, Elham Tabesh, Peyman Adibi
Arch Iran Med. 2024;27(8): 407-413. doi: 10.34172/aim.31072
PMCID: PMC11416694     PMID: 39306711     Scopus ID: 85201917722    
Article
PDF
XML
Cited By:
0
Original Article

7. Screening of Hearing in Newborn Infants: Follow-Up and Outcome After 40930 Births in Babol, Northern Iran
Yadollah Zahed Pasha, Mohammad Zamani*, Ali Hashemi Fard, Ermia Zahed Pasha
Arch Iran Med. 2018;21(9): 382-386.
PMID: 30221527     Scopus ID: 85059581150    
Article
PDF
XML
Cited By:
3
4
Review Article

8. Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures
Elham Akbarpour ORCID, Alireza Sadjadi* ORCID, Mohammad H. Derakhshan ORCID, Gholamreza Roshandel ORCID, Masoomeh Alimohammadian
Arch Iran Med. 2021;24(7): 556-567. doi: 10.34172/aim.2021.79
Scopus ID: 85114119018    
Article
PDF
XML
Cited By:
11
10
Systematic Review COVID-19

9. Screening for Mental Health Problems in Epidemics: Is It Justifiable?

Vandad Sharifi ORCID, Atefeh Mohammadjafari* ORCID
Arch Iran Med. 2021;24(8): 643-650. doi: 10.34172/aim.2021.91
Scopus ID: 85114107245    
Article
PDF
XML
Cited By:
0
0


SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.